91直播

The University of Manchester (UoM) and Shell Research Limited (Shell) have come together in a Prosperity Partnership worth over 拢9 million to find new sustainable routes to manufacturing commodity chemicals, while also de-risking the process for industry. 

The Sustainable Commodity Chemicals through Enzyme Engineering and Design (SuCCEED) project will look to find new ways of manufacturing the chemicals needed for many every-day products through industrial biotechnology routes. By doing this, it will help the chemical manufacturing industry move away from fossil-based feedstocks and reduce their carbon footprint. 

Bio-based manufacturing routes are not currently widespread as they are difficult to scale up and don鈥檛 operate at the profit margins required for commodity chemicals. This poses a barrier to moving the chemicals industry away from petrochemicals and creating a greener industry. 

To help address this, the Prosperity Partnerships bring together industry and academia to find workable solutions to industry-based problems. The 91直播 Institute of Biotechnology (MIB) and Shell have assembled an interdisciplinary team, led by , of biochemists, protein engineers, synthetic biologists, chemists, and chemical engineers to create a proof-of-principle, scalable, biorefinery. 

If successful, this 5-year project could help reshape the chemicals industry and support the UK delivering on its clean growth strategy.

Jeremy Shears, Chief Scientist for Biosciences at Shell said: 鈥淪hell aims to transition to a net-zero emissions energy business by 2050 and our work with the 91直播 Institute of Biotechnology is important to unlock a more commercial route to sustainably produced chemicals. If we can demonstrate an effective route to bio-production, we hope this will be the catalyst for industrial change across the sector.鈥�

Science, Research and Innovation Minister, Andrew Griffith, said:

鈥淥ur new bioscience prosperity partnerships are a valuable opportunity for government, business and academia to come together and help unleash world-class, pioneering discoveries across the UK while growing our local economies.

鈥淢ore than 拢17m of Government funding is backing vital projects including work in Belfast to unearth life-saving drugs, in 91直播 to improve skin health research and in Cambridge to tackle a major source of global pollution 鈥� enhancing the health and wellbeing of people across our country and beyond.鈥�

Dr Lee Beniston FRSB, Associate Director for Industry Partnerships and Collaborative R&D at BBSRC, said:

鈥淭he inaugural round of the BBSRC prosperity partnerships programme has been a huge success. Led by BBSRC, with investment from our colleagues at MRC and EPSRC, we will invest more than 拢17 million in ten projects.

鈥淭his investment will support outstanding, long-term collaborative partnerships between businesses and academic researchers across the UK. Through the BBSRC prosperity partnerships programme, the businesses involved are investing over 拢21 million into research and development.

鈥淭he projects supported will deliver on UK ambitions for private sector investment in research and innovation as outlined in the Science and Technology Framework, helping to drive economic growth and societal impact through key bioscience and biotechnology sectors and industries.鈥�

Industrial biotechnology uses nature鈥檚 own processes to produce value-added products, it is currently used to produce high-value chemicals such as pharmaceuticals. Enzymes and bacteria are the staple workhorses of biocatalysis 鈥� a process that speeds up chemical reactions 鈥� and can produce target chemicals by using anything from biomass to anthropogenic waste as a feedstock. Industrial biotechnology holds huge potential for creating a sustainable manufacturing environment and supporting the world鈥檚 transition to net zero.

The University was also successful in securing a second Prosperity Partnership with Boots, and co-leading a third with University College London.